LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-small Cell Lung Cancer Plasticity and Therapeutic Response.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Cancer Cell

• Publication date

  2015-05-11

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.ccell.2015.04.001PMID 25936644PMCID PMC4746728
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expression.

  2014cited by this paper
• Analysis of Major Known Driver Mutations and Prognosis in Resected Adenosquamous Lung Carcinomas

  2014cited by this paper
• Multiple cells-of-origin of mutant K-Ras–induced mouse lung adenocarcinoma

  2014cited by this paper
• YAP inhibits squamous transdifferentiation of Lkb1-deficient lung adenocarcinoma through ZEB2-dependent DNp63 repression

  2014cited by this paper
• Non-small-cell lung cancers: a heterogeneous set of diseases

  2014cited by this paper
• Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinoma

  2014cited by this paper
• Sox2 Cooperates with Lkb1 Loss in a Mouse Model of Squamous Cell Lung Cancer

  2014cited by this paper
• Systematic identification of molecular subtype-selective vulnerabilities in non-small-cell lung cancer.

  2013cited by this paper
• A genetic screen identifies an LKB1–MARK signalling axis controlling the Hippo–YAP pathway

  2013cited by this paper
• Genomic landscape of non-small-cell lung cancer in smokers and never-smokers

  2013cited by this paper
• Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2.

  2013cited by this paper
• Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF.

  2013cited by this paper
• The LKB1-AMPK pathway-friend or foe in cancer?

  2013cited by this paper
• PGC1α expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress.

  2013cited by this paper
• LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin.

  2013cited by this paper
• Efficacy of BET Bromodomain Inhibition in Kras-Mutant Non–Small Cell Lung Cancer

  2013cited by this paper
• SnapShot: non-small cell lung cancer.

  2012cited by this paper
• A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response

  2012cited by this paper
• Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.

  2012cited by this paper
• SnapShot: Lung cancer models.

  2012cited by this paper
• Metabolic reprogramming: a cancer hallmark even warburg did not anticipate.

  2012cited by this paper
• AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress

  2012cited by this paper
• NRF2 and cancer: the good, the bad and the importance of context

  2012cited by this paper
• Genomic landscape of non-small cell lung cancer in smokers and never-smokers.

  2012cited by this paper
• AMPK: a nutrient and energy sensor that maintains energy homeostasis

  2012cited by this paper
• Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis

  2011cited by this paper
• Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress.

  2011cited by this paper
• Selective killing of cancer cells with a small molecule targeting stress response to ROS

  2011cited by this paper
• Regulation of cancer cell metabolism

  2011cited by this paper
• Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens

  2011cited by this paper
• Cell of origin of small cell lung cancer: inactivation of Trp53 and Rb1 in distinct cell types of adult mouse lung.

  2011cited by this paper
• Targeting metabolic transformation for cancer therapy

  2010cited by this paper
• Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells

  2010cited by this paper
• LKB1 regulates quiescence and metabolic homeostasis of hematopoietic stem cells

  2010cited by this paper
• LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling

  2010cited by this paper
• Spectrum of LKB1, EGFR, and KRAS Mutations in Chinese Lung Adenocarcinomas

  2010cited by this paper
• The Lkb1 metabolic sensor maintains haematopoietic stem cell survival

  2010cited by this paper
• Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases.

  2010cited by this paper
• Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

  2009cited by this paper
• The LKB1–AMPK pathway: metabolism and growth control in tumour suppression

  2009cited by this paper
• TSC1 loss synergizes with KRAS activation in lung cancer development in the mouse and confers rapamycin sensitivity

  2009cited by this paper
• Overexpression of Carnitine Palmitoyltransferase-1 in Skeletal Muscle Is Sufficient to Enhance Fatty Acid Oxidation and Improve High-Fat Diet–Induced Insulin Resistance

  2009cited by this paper
• Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase

  2009cited by this paper
• Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment

  2009cited by this paper
• Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice.

  2008cited by this paper
• ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis

  2007cited by this paper
• Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism

  2007cited by this paper
• LKB1 modulates lung cancer differentiation and metastasis

  2007cited by this paper
• Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice

  2006cited by this paper
• LKB1-dependent signaling pathways.

  2006cited by this paper
• Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver.

  2005cited by this paper
• Glutathione metabolism and its implications for health.

  2004cited by this paper
• Early restriction of peripheral and proximal cell lineages during formation of the lung

  2002cited by this paper
• Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation

  2002cited by this paper
• Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

  2001cited by this paper
• Human glucose‐6‐phosphate dehydrogenase (G6PD) gene transforms NIH 3T3 cells and induces tumors in nude mice

  2000cited by this paper
• Enhanced Glutathione Levels and Oxidoresistance Mediated by Increased Glucose-6-phosphate Dehydrogenase Expression*

  1999cited by this paper
• Modeling human lung cancer in mice: similarities and shortcomings

  1999cited by this paper

• Tumor cell-specific loss of GPX4 reprograms triacylglycerol metabolism to escape ferroptosis and impair antitumor immunity in NSCLC

  2025cites this paper
• Tumor suppressor genes and KRAS G12C inhibitor resistance in non-small cell lung cancer

  2025cites this paper
• Exploring the role of ELOVLs family in lung adenocarcinoma based on bioinformatic analysis and experimental validation

  2025cites this paper
• Transcriptional regulation by LKB1 in lung adenocarcinomas: Exploring oxidative stress, neuroglial and amino acid signatures.

  2025cites this paper
• A phase II trial of mTORC1/2 inhibition in STK11 deficient non small cell lung cancer

  2025cites this paper
• KLF4 promotes a KRT13+ hillock-like state in squamous lung cancer

  2025cites this paper
• Lung cancer-intrinsic SOX2 expression mediates resistance to checkpoint blockade therapy by inducing Treg cell-dependent CD8+ T-cell exclusion.

  2025cites this paper
• Unraveling the immune mechanisms and therapeutic targets in lung adenosquamous transformation

  2025cites this paper
• Involvement of KEAP1/NRF2 pathway in non‐BRAF mutated squamous cell carcinoma of the thyroid

  2025cites this paper
• KEAP1 and STK11/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant non-small cell lung cancer.

  2025cites this paper
• Targeting LKB1/STK11-mutant cancer: distinct metabolism, microenvironment, and therapeutic resistance.

  2025cites this paper
• High-dose ascorbic acid selectively induces pyroptosis in LKB1-deficient lung cancer and sensitizes immunotherapy

  2025cites this paper
• Comments on ‘Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer’

  2024cites this paper
• LKB1 Mutations Enhance Radiosensitivity in Non-Small Cell Lung Cancer Cells by Inducing G2/M Cell Cycle Phase Arrest.

  2024cites this paper
• EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation

  2024cites this paper
• Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade

  2024cites this paper
• Antitumor Effects of Carrier-Free Functionalized Lignin Materials on Human Hepatocellular Carcinoma (HepG2) Cells.

  2024cites this paper
• Advanced Lung Adenocarcinoma with EGFR 19-del Mutation Transformed into SCC after EGFR-tyrosine Kinase inhibitors Treatment: A Case report

  2024cites this paper
• Gene therapy for diffuse pleural mesotheliomas in preclinical models by concurrent expression of NF2 and SuperHippo

  2024cites this paper
• Cancer plasticity in therapy resistance: Mechanisms and novel strategies.

  2024cites this paper
• Integrative study of lung cancer adeno-to-squamous transition in EGFR TKI resistance identifies RAPGEF3 as a therapeutic target

  2024cites this paper
• LKB1 regulates JNK-dependent stress signaling and apoptotic dependency of KRAS-mutant lung cancers

  2024cites this paper
• Understanding cachexia and its impact on lung cancer and beyond

  2024cites this paper
• Emerging horizons in cancer therapy: Squamous transition drives drug resistance

  2024cites this paper
• TET2–STAT3–CXCL5 nexus promotes neutrophil lipid transfer to fuel lung adeno-to-squamous transition

  2024cites this paper
• First insight about the ability of specific glycerophospholipids to discriminate non-small cell lung cancer subtypes

  2024cites this paper
• Redoxhigh phenotype mediated by KEAP1/STK11/SMARCA4/NRF2 mutations diminishes tissue-resident memory CD8+ T cells and attenuates the efficacy of immunotherapy in lung adenocarcinoma

  2024cites this paper
• Energy metabolism as the hub of advanced non-small cell lung cancer management: a comprehensive view in the framework of predictive, preventive, and personalized medicine

  2024cites this paper
• Ferroptosis, Acyl Starvation, and Breast Cancer

  2023cites this paper
• An antioxidant feedforward cycle coordinated by linker histone variant H1.2 and NRF2 that drives nonsmall cell lung cancer progression

  2023cites this paper
• Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer

  2023cites this paper
• Identification and comprehensive analysis of super-enhancer related genes involved in epithelial-to-mesenchymal transition in lung adenocarcinoma

  2023cites this paper
• MRPL51 is a downstream target of FOXM1 in promoting the malignant behaviors of lung adenocarcinoma

  2023cites this paper
• Stevioside Improves Antioxidant Capacity and Intestinal Barrier Function while Attenuating Inflammation and Apoptosis by Regulating the NF-κB/MAPK Pathways in Diquat-Induced Oxidative Stress of IPEC-J2 Cells

  2023cites this paper
• Counteracting lineage-specific transcription factor network finely tunes lung adeno-to-squamous transdifferentiation through remodeling tumor immune microenvironment

  2023cites this paper
• The nature of cancer

  2023cites this paper
• Redox signaling in drug-tolerant persister cells as an emerging therapeutic target

  2023cites this paper
• LKB1-Dependent Regulation of TPI1 Creates a Divergent Metabolic Liability between Human and Mouse Lung Adenocarcinoma

  2023cites this paper
• Oxidative stress-triggered Wnt signaling perturbation characterizes the tipping point of lung adeno-to-squamous transdifferentiation

  2023cites this paper
• Battles against aberrant KEAP1-NRF2 signaling in lung cancer: intertwined metabolic and immune networks

  2023influential citation
• Reprogramming of Lipid Metabolism in Lung Cancer: An Overview with Focus on EGFR-Mutated Non-Small Cell Lung Cancer

  2022cites this paper
• RAS: Circuitry and therapeutic targeting.

  2022cites this paper
• miR-199a: A Tumor Suppressor with Noncoding RNA Network and Therapeutic Candidate in Lung Cancer

  2022cites this paper
• Resistance of Lenvatinib in Hepatocellular Carcinoma.

  2022cites this paper
• Therapeutic targeting of the mevalonate–geranylgeranyl diphosphate pathway with statins overcomes chemotherapy resistance in small cell lung cancer

  2022cites this paper
• AMPK induces degradation of the transcriptional repressor PROX1 impairing branched amino acid metabolism and tumourigenesis

  2022cites this paper
• Lung Adenocarcinoma Tumor Origin: A Guide for Personalized Medicine

  2022cites this paper
• NRF2: KEAPing Tumors Protected.

  2022cites this paper
• Non-conserved metabolic regulation by LKB1 distinguishes human and mouse lung adenocarcinoma

  2021cites this paper
• Modulating Tumor Microenvironment: A Review on STK11 Immune Properties and Predictive vs Prognostic Role for Non-small-cell Lung Cancer Immunotherapy

  2021cites this paper
• Adenocarcinoma transformed into squamous cell carcinoma in non-small cell lung cancer.

  2021cites this paper
• Focal Adhesion Kinase (FAK) Inhibition Synergizes with KRAS G12C Inhibitors in Treating Cancer through the Regulation of the FAK–YAP Signaling

  2021cites this paper
• Case Report: EGFR-Positive Early-Stage Lung Adenocarcinoma Transforming to Squamous Cell Carcinoma After TKI Treatment

  2021cites this paper
• Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence

  2021cites this paper
• A systematic dissection of the epigenomic heterogeneity of lung adenocarcinoma reveals two different subclasses with distinct prognosis and core regulatory networks

  2021cites this paper
• Phase separation of EML4–ALK in firing downstream signaling and promoting lung tumorigenesis

  2021cites this paper
• Integrative analysis of multi‐omics data reveals the heterogeneity and signatures of immune therapy for small cell lung cancer

  2021cites this paper
• Targeting HSPA1A in ARID2-deficient lung adenocarcinoma

  2021cites this paper
• Stem cells and lung cancer

  2021cites this paper
• Lung stem cells in regeneration and tumorigenesis.

  2021cites this paper
• The Metabolic Landscape of RAS-Driven Cancers from biology to therapy

  2021cites this paper
• Oxidative Stress and the Intersection of Oncogenic Signaling and Metabolism in Squamous Cell Carcinomas

  2021cites this paper
• Recent advances in preclinical models for lung squamous cell carcinoma

  2021cites this paper
• Resveratrol-induced Sirt1 phosphorylation by LKB1 mediates mitochondrial metabolism

  2021cites this paper
• Phase separation of EML4–ALK in firing downstream signaling and promoting lung tumorigenesis

  2021cites this paper
• Nanog maintains stemness of Lkb1‐deficient lung adenocarcinoma and prevents gastric differentiation

  2021cites this paper
• LKB1/STK11 is a tumor suppressor in the progression of myeloproliferative neoplasms.

  2021cites this paper
• Small-Molecule Prodrug Nanoassemblies: An Emerging Nanoplatform for Anticancer Drug Delivery.

  2021cites this paper
• JNK(1/2) represses Lkb(1)-deficiency-induced lung squamous JNK(1/2) represses Lkb(1)-deficiency-induced lung squamous cell carcinoma progression cell carcinoma progression Let us know how access to this document benefits you.

  2021cites this paper
• Cell reprogramming in liver with potential clinical correlations

  2021cites this paper
• Primary tumor location in lung cancer: the evaluation and administration

  2021cites this paper
• Hotspots and trends in liver kinase B1 research: A bibliometric analysis

  2021cites this paper
• Enhanced Vulnerability of LKB1-Deficient NSCLC to Disruption of ATP Pools and Redox Homeostasis by 8-Cl-Ado

  2021cites this paper
• Heme Sequestration Effectively Suppresses the Development and Progression of Both Lung Adenocarcinoma and Squamous Cell Carcinoma

  2021cites this paper
• Chromobox 4 facilitates tumorigenesis of lung adenocarcinoma through the Wnt/β-catenin pathway

  2020cites this paper
• Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) in non-small cell lung cancer.

  2020cites this paper
• BCAT2-mediated BCAA catabolism is critical for development of pancreatic ductal adenocarcinoma

  2020cites this paper
• Histologic transformation of lung adenocarcinoma to squamous cell carcinoma after chemotherapy: two case reports

  2020influential citation
• NOD2 inhibits tumorigenesis and increases chemosensitivity of hepatocellular carcinoma by targeting AMPK pathway

  2020cites this paper
• Understanding Lineage Plasticity as a Path to Targeted Therapy Failure in EGFR-Mutant Non-small Cell Lung Cancer

  2020cites this paper
• Cancer Cells Don't Live Alone: Metabolic Communication within Tumor Microenvironments.

  2020cites this paper
• LKB1 and cancer: The dual role of metabolic regulation.

  2020cites this paper
• NRF2 Activation Promotes Aggressive Lung Cancer and Associates with Poor Clinical Outcomes

  2020cites this paper
• Cells of origin of lung cancers: lessons from mouse studies

  2020cites this paper
• Shining a light on metabolic vulnerabilities in non-small cell lung cancer.

  2020influential citation
• Deciphering the clonal relationship between glandular and squamous components in adenosquamous carcinoma of the lung using whole exome sequencing.

  2020cites this paper
• In vivo miRNA knockout screening identifies miR-190b as a novel tumor suppressor

  2020cites this paper
• CCL7 recruits cDC1 to promote antitumor immunity and facilitate checkpoint immunotherapy to non-small cell lung cancer

  2020cites this paper
• Mild Oxidative Stress Reduces NRF2 SUMOylation to Promote Kras/Lkb1/Keap1 Mutant Lung Adenocarcinoma Cell Migration and Invasion

  2020cites this paper
• STK11/LKB1 Mutations in NSCLC Are Associated with KEAP1/NRF2-Dependent Radiotherapy Resistance Targetable by Glutaminase Inhibition

  2020cites this paper
• Efficacy and Biomarker Analysis of Camrelizumab in Combination with Apatinib in Patients with Advanced Nonsquamous NSCLC Previously Treated with Chemotherapy

  2020cites this paper
• miR-218 inhibits glucose metabolism in non-small cell lung cancer via the NF-κB signaling pathway.

  2020cites this paper
• Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectories

  2020cites this paper
• Transfer of cGAMP into Bystander Cells via LRRC8 Volume-Regulated Anion Channels Augments STING-Mediated Interferon Responses and Anti-viral Immunity.

  2020cites this paper
• Branched-Chain Amino Acid Metabolic Reprogramming Orchestrates Drug Resistance to EGFR Tyrosine Kinase Inhibitors

  2019cites this paper
• LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective

  2019influential citation
• Synthetic lethality targeting LKB1 mutant and EGFR wild type human non-small cell lung cancer cells by glucose starvation and SGLT2 inhibition

  2019cites this paper
• Cullin5 deficiency promotes small-cell lung cancer metastasis by stabilizing integrin &bgr;1

  2019cites this paper
• LKB1 and KEAP1/NRF2 pathways cooperatively promote metabolic reprogramming with enhanced glutamine dependence in KRAS-mutant lung adenocarcinoma.

  2019cites this paper
• Autophagy modulates lipid metabolism to maintain metabolic flexibility for Lkb1-deficient Kras-driven lung tumorigenesis

  2019cites this paper